Global H1N1 Vaccines Market Growth 2025-2031
The global H1N1 Vaccines market size is predicted to grow from US$ 4903 million in 2025 to US$ 5946 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “H1N1 Vaccines Industry Forecast” looks at past sales and reviews total world H1N1 Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected H1N1 Vaccines sales for 2025 through 2031. With H1N1 Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world H1N1 Vaccines industry.
This Insight Report provides a comprehensive analysis of the global H1N1 Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on H1N1 Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global H1N1 Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for H1N1 Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global H1N1 Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of H1N1 Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global H1N1 Vaccines market?
What factors are driving H1N1 Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do H1N1 Vaccines market opportunities vary by end market size?
How does H1N1 Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “H1N1 Vaccines Industry Forecast” looks at past sales and reviews total world H1N1 Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected H1N1 Vaccines sales for 2025 through 2031. With H1N1 Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world H1N1 Vaccines industry.
This Insight Report provides a comprehensive analysis of the global H1N1 Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on H1N1 Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global H1N1 Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for H1N1 Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global H1N1 Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of H1N1 Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Intramuscular Vaccines
- Intranasal Vaccines
- Intradermal Vaccines
- Influenza
- Meningococcal
- Cervical Cancer
- Pneumococcal
- Hepatitis
- Measles
- Mumps
- Rubella
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Baxter International
- Sanofi
- GSK
- Pfizer
- Mitsubishi Tanabe Pharma
- Hualan Biological Engineering
- Cipla
- Merck
- Sinovac Biotech
What is the 10-year outlook for the global H1N1 Vaccines market?
What factors are driving H1N1 Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do H1N1 Vaccines market opportunities vary by end market size?
How does H1N1 Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Clostridium Vaccine Market Size (2020-2031)
2.1.2 Veterinary Clostridium Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Veterinary Clostridium Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Veterinary Clostridium Vaccine Segment by Objects
2.2.1 Bovine
2.2.2 Ovine
2.2.3 Caprine
2.2.4 Swine
2.2.5 Poultry
2.3 Veterinary Clostridium Vaccine Market Size by Objects
2.3.1 Veterinary Clostridium Vaccine Market Size CAGR by Objects (2020 VS 2024 VS 2031)
2.3.2 Global Veterinary Clostridium Vaccine Market Size Market Share by Objects (2020-2025)
2.4 Veterinary Clostridium Vaccine Segment by Application
2.4.1 Veterinary Clinic
2.4.2 Veterinary Hospital
2.4.3 Veterinary Research Institute
2.4.4 Retail Pharmacy
2.4.5 Others
2.5 Veterinary Clostridium Vaccine Market Size by Application
2.5.1 Veterinary Clostridium Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Veterinary Clostridium Vaccine Market Size Market Share by Application (2020-2025)
3 VETERINARY CLOSTRIDIUM VACCINE MARKET SIZE BY PLAYER
3.1 Veterinary Clostridium Vaccine Market Size Market Share by Player
3.1.1 Global Veterinary Clostridium Vaccine Revenue by Player (2020-2025)
3.1.2 Global Veterinary Clostridium Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Veterinary Clostridium Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VETERINARY CLOSTRIDIUM VACCINE BY REGION
4.1 Veterinary Clostridium Vaccine Market Size by Region (2020-2025)
4.2 Global Veterinary Clostridium Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.4 APAC Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.5 Europe Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Veterinary Clostridium Vaccine Market Size by Country (2020-2025)
5.2 Americas Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
5.3 Americas Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Clostridium Vaccine Market Size by Region (2020-2025)
6.2 APAC Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
6.3 APAC Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Veterinary Clostridium Vaccine Market Size by Country (2020-2025)
7.2 Europe Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
7.3 Europe Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Clostridium Vaccine by Region (2020-2025)
8.2 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
8.3 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VETERINARY CLOSTRIDIUM VACCINE MARKET FORECAST
10.1 Global Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.1.1 Global Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.1.2 Americas Veterinary Clostridium Vaccine Forecast
10.1.3 APAC Veterinary Clostridium Vaccine Forecast
10.1.4 Europe Veterinary Clostridium Vaccine Forecast
10.1.5 Middle East & Africa Veterinary Clostridium Vaccine Forecast
10.2 Americas Veterinary Clostridium Vaccine Forecast by Country (2026-2031)
10.2.1 United States Market Veterinary Clostridium Vaccine Forecast
10.2.2 Canada Market Veterinary Clostridium Vaccine Forecast
10.2.3 Mexico Market Veterinary Clostridium Vaccine Forecast
10.2.4 Brazil Market Veterinary Clostridium Vaccine Forecast
10.3 APAC Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.3.1 China Veterinary Clostridium Vaccine Market Forecast
10.3.2 Japan Market Veterinary Clostridium Vaccine Forecast
10.3.3 Korea Market Veterinary Clostridium Vaccine Forecast
10.3.4 Southeast Asia Market Veterinary Clostridium Vaccine Forecast
10.3.5 India Market Veterinary Clostridium Vaccine Forecast
10.3.6 Australia Market Veterinary Clostridium Vaccine Forecast
10.4 Europe Veterinary Clostridium Vaccine Forecast by Country (2026-2031)
10.4.1 Germany Market Veterinary Clostridium Vaccine Forecast
10.4.2 France Market Veterinary Clostridium Vaccine Forecast
10.4.3 UK Market Veterinary Clostridium Vaccine Forecast
10.4.4 Italy Market Veterinary Clostridium Vaccine Forecast
10.4.5 Russia Market Veterinary Clostridium Vaccine Forecast
10.5 Middle East & Africa Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.5.1 Egypt Market Veterinary Clostridium Vaccine Forecast
10.5.2 South Africa Market Veterinary Clostridium Vaccine Forecast
10.5.3 Israel Market Veterinary Clostridium Vaccine Forecast
10.5.4 Turkey Market Veterinary Clostridium Vaccine Forecast
10.6 Global Veterinary Clostridium Vaccine Forecast by Objects (2026-2031)
10.7 Global Veterinary Clostridium Vaccine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Veterinary Clostridium Vaccine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Elanco
11.1.1 Elanco Company Information
11.1.2 Elanco Veterinary Clostridium Vaccine Product Offered
11.1.3 Elanco Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Elanco Main Business Overview
11.1.5 Elanco Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Veterinary Clostridium Vaccine Product Offered
11.2.3 Merck Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Merial
11.3.1 Merial Company Information
11.3.2 Merial Veterinary Clostridium Vaccine Product Offered
11.3.3 Merial Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merial Main Business Overview
11.3.5 Merial Latest Developments
11.4 Zoetis
11.4.1 Zoetis Company Information
11.4.2 Zoetis Veterinary Clostridium Vaccine Product Offered
11.4.3 Zoetis Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Zoetis Main Business Overview
11.4.5 Zoetis Latest Developments
11.5 Advaxis
11.5.1 Advaxis Company Information
11.5.2 Advaxis Veterinary Clostridium Vaccine Product Offered
11.5.3 Advaxis Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Advaxis Main Business Overview
11.5.5 Advaxis Latest Developments
11.6 Ampliphi
11.6.1 Ampliphi Company Information
11.6.2 Ampliphi Veterinary Clostridium Vaccine Product Offered
11.6.3 Ampliphi Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Ampliphi Main Business Overview
11.6.5 Ampliphi Latest Developments
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Information
11.7.2 Aratana Therapeutics Veterinary Clostridium Vaccine Product Offered
11.7.3 Aratana Therapeutics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aratana Therapeutics Main Business Overview
11.7.5 Aratana Therapeutics Latest Developments
11.8 ARKO Labs
11.8.1 ARKO Labs Company Information
11.8.2 ARKO Labs Veterinary Clostridium Vaccine Product Offered
11.8.3 ARKO Labs Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 ARKO Labs Main Business Overview
11.8.5 ARKO Labs Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Veterinary Clostridium Vaccine Product Offered
11.9.3 Bayer Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Information
11.10.2 CanFel Therapeutics Veterinary Clostridium Vaccine Product Offered
11.10.3 CanFel Therapeutics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 CanFel Therapeutics Main Business Overview
11.10.5 CanFel Therapeutics Latest Developments
11.11 Ceva
11.11.1 Ceva Company Information
11.11.2 Ceva Veterinary Clostridium Vaccine Product Offered
11.11.3 Ceva Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Ceva Main Business Overview
11.11.5 Ceva Latest Developments
11.12 Colorado Serum
11.12.1 Colorado Serum Company Information
11.12.2 Colorado Serum Veterinary Clostridium Vaccine Product Offered
11.12.3 Colorado Serum Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Colorado Serum Main Business Overview
11.12.5 Colorado Serum Latest Developments
11.13 Epitopix
11.13.1 Epitopix Company Information
11.13.2 Epitopix Veterinary Clostridium Vaccine Product Offered
11.13.3 Epitopix Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Epitopix Main Business Overview
11.13.5 Epitopix Latest Developments
11.14 Genus
11.14.1 Genus Company Information
11.14.2 Genus Veterinary Clostridium Vaccine Product Offered
11.14.3 Genus Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Genus Main Business Overview
11.14.5 Genus Latest Developments
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Information
11.15.2 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Product Offered
11.15.3 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Hygieia Biological Laboratories Main Business Overview
11.15.5 Hygieia Biological Laboratories Latest Developments
11.16 Nexvet
11.16.1 Nexvet Company Information
11.16.2 Nexvet Veterinary Clostridium Vaccine Product Offered
11.16.3 Nexvet Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Nexvet Main Business Overview
11.16.5 Nexvet Latest Developments
11.17 Nuovo Biologics
11.17.1 Nuovo Biologics Company Information
11.17.2 Nuovo Biologics Veterinary Clostridium Vaccine Product Offered
11.17.3 Nuovo Biologics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nuovo Biologics Main Business Overview
11.17.5 Nuovo Biologics Latest Developments
11.18 Valneva
11.18.1 Valneva Company Information
11.18.2 Valneva Veterinary Clostridium Vaccine Product Offered
11.18.3 Valneva Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Valneva Main Business Overview
11.18.5 Valneva Latest Developments
11.19 Vetoquinol
11.19.1 Vetoquinol Company Information
11.19.2 Vetoquinol Veterinary Clostridium Vaccine Product Offered
11.19.3 Vetoquinol Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Vetoquinol Main Business Overview
11.19.5 Vetoquinol Latest Developments
11.20 Virbac
11.20.1 Virbac Company Information
11.20.2 Virbac Veterinary Clostridium Vaccine Product Offered
11.20.3 Virbac Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Virbac Main Business Overview
11.20.5 Virbac Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Clostridium Vaccine Market Size (2020-2031)
2.1.2 Veterinary Clostridium Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Veterinary Clostridium Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Veterinary Clostridium Vaccine Segment by Objects
2.2.1 Bovine
2.2.2 Ovine
2.2.3 Caprine
2.2.4 Swine
2.2.5 Poultry
2.3 Veterinary Clostridium Vaccine Market Size by Objects
2.3.1 Veterinary Clostridium Vaccine Market Size CAGR by Objects (2020 VS 2024 VS 2031)
2.3.2 Global Veterinary Clostridium Vaccine Market Size Market Share by Objects (2020-2025)
2.4 Veterinary Clostridium Vaccine Segment by Application
2.4.1 Veterinary Clinic
2.4.2 Veterinary Hospital
2.4.3 Veterinary Research Institute
2.4.4 Retail Pharmacy
2.4.5 Others
2.5 Veterinary Clostridium Vaccine Market Size by Application
2.5.1 Veterinary Clostridium Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Veterinary Clostridium Vaccine Market Size Market Share by Application (2020-2025)
3 VETERINARY CLOSTRIDIUM VACCINE MARKET SIZE BY PLAYER
3.1 Veterinary Clostridium Vaccine Market Size Market Share by Player
3.1.1 Global Veterinary Clostridium Vaccine Revenue by Player (2020-2025)
3.1.2 Global Veterinary Clostridium Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Veterinary Clostridium Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VETERINARY CLOSTRIDIUM VACCINE BY REGION
4.1 Veterinary Clostridium Vaccine Market Size by Region (2020-2025)
4.2 Global Veterinary Clostridium Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.4 APAC Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.5 Europe Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Veterinary Clostridium Vaccine Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Veterinary Clostridium Vaccine Market Size by Country (2020-2025)
5.2 Americas Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
5.3 Americas Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Clostridium Vaccine Market Size by Region (2020-2025)
6.2 APAC Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
6.3 APAC Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Veterinary Clostridium Vaccine Market Size by Country (2020-2025)
7.2 Europe Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
7.3 Europe Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Clostridium Vaccine by Region (2020-2025)
8.2 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Objects (2020-2025)
8.3 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VETERINARY CLOSTRIDIUM VACCINE MARKET FORECAST
10.1 Global Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.1.1 Global Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.1.2 Americas Veterinary Clostridium Vaccine Forecast
10.1.3 APAC Veterinary Clostridium Vaccine Forecast
10.1.4 Europe Veterinary Clostridium Vaccine Forecast
10.1.5 Middle East & Africa Veterinary Clostridium Vaccine Forecast
10.2 Americas Veterinary Clostridium Vaccine Forecast by Country (2026-2031)
10.2.1 United States Market Veterinary Clostridium Vaccine Forecast
10.2.2 Canada Market Veterinary Clostridium Vaccine Forecast
10.2.3 Mexico Market Veterinary Clostridium Vaccine Forecast
10.2.4 Brazil Market Veterinary Clostridium Vaccine Forecast
10.3 APAC Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.3.1 China Veterinary Clostridium Vaccine Market Forecast
10.3.2 Japan Market Veterinary Clostridium Vaccine Forecast
10.3.3 Korea Market Veterinary Clostridium Vaccine Forecast
10.3.4 Southeast Asia Market Veterinary Clostridium Vaccine Forecast
10.3.5 India Market Veterinary Clostridium Vaccine Forecast
10.3.6 Australia Market Veterinary Clostridium Vaccine Forecast
10.4 Europe Veterinary Clostridium Vaccine Forecast by Country (2026-2031)
10.4.1 Germany Market Veterinary Clostridium Vaccine Forecast
10.4.2 France Market Veterinary Clostridium Vaccine Forecast
10.4.3 UK Market Veterinary Clostridium Vaccine Forecast
10.4.4 Italy Market Veterinary Clostridium Vaccine Forecast
10.4.5 Russia Market Veterinary Clostridium Vaccine Forecast
10.5 Middle East & Africa Veterinary Clostridium Vaccine Forecast by Region (2026-2031)
10.5.1 Egypt Market Veterinary Clostridium Vaccine Forecast
10.5.2 South Africa Market Veterinary Clostridium Vaccine Forecast
10.5.3 Israel Market Veterinary Clostridium Vaccine Forecast
10.5.4 Turkey Market Veterinary Clostridium Vaccine Forecast
10.6 Global Veterinary Clostridium Vaccine Forecast by Objects (2026-2031)
10.7 Global Veterinary Clostridium Vaccine Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Veterinary Clostridium Vaccine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Elanco
11.1.1 Elanco Company Information
11.1.2 Elanco Veterinary Clostridium Vaccine Product Offered
11.1.3 Elanco Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Elanco Main Business Overview
11.1.5 Elanco Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Veterinary Clostridium Vaccine Product Offered
11.2.3 Merck Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Merial
11.3.1 Merial Company Information
11.3.2 Merial Veterinary Clostridium Vaccine Product Offered
11.3.3 Merial Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Merial Main Business Overview
11.3.5 Merial Latest Developments
11.4 Zoetis
11.4.1 Zoetis Company Information
11.4.2 Zoetis Veterinary Clostridium Vaccine Product Offered
11.4.3 Zoetis Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Zoetis Main Business Overview
11.4.5 Zoetis Latest Developments
11.5 Advaxis
11.5.1 Advaxis Company Information
11.5.2 Advaxis Veterinary Clostridium Vaccine Product Offered
11.5.3 Advaxis Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Advaxis Main Business Overview
11.5.5 Advaxis Latest Developments
11.6 Ampliphi
11.6.1 Ampliphi Company Information
11.6.2 Ampliphi Veterinary Clostridium Vaccine Product Offered
11.6.3 Ampliphi Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Ampliphi Main Business Overview
11.6.5 Ampliphi Latest Developments
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Information
11.7.2 Aratana Therapeutics Veterinary Clostridium Vaccine Product Offered
11.7.3 Aratana Therapeutics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Aratana Therapeutics Main Business Overview
11.7.5 Aratana Therapeutics Latest Developments
11.8 ARKO Labs
11.8.1 ARKO Labs Company Information
11.8.2 ARKO Labs Veterinary Clostridium Vaccine Product Offered
11.8.3 ARKO Labs Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 ARKO Labs Main Business Overview
11.8.5 ARKO Labs Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Veterinary Clostridium Vaccine Product Offered
11.9.3 Bayer Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Information
11.10.2 CanFel Therapeutics Veterinary Clostridium Vaccine Product Offered
11.10.3 CanFel Therapeutics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 CanFel Therapeutics Main Business Overview
11.10.5 CanFel Therapeutics Latest Developments
11.11 Ceva
11.11.1 Ceva Company Information
11.11.2 Ceva Veterinary Clostridium Vaccine Product Offered
11.11.3 Ceva Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Ceva Main Business Overview
11.11.5 Ceva Latest Developments
11.12 Colorado Serum
11.12.1 Colorado Serum Company Information
11.12.2 Colorado Serum Veterinary Clostridium Vaccine Product Offered
11.12.3 Colorado Serum Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Colorado Serum Main Business Overview
11.12.5 Colorado Serum Latest Developments
11.13 Epitopix
11.13.1 Epitopix Company Information
11.13.2 Epitopix Veterinary Clostridium Vaccine Product Offered
11.13.3 Epitopix Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Epitopix Main Business Overview
11.13.5 Epitopix Latest Developments
11.14 Genus
11.14.1 Genus Company Information
11.14.2 Genus Veterinary Clostridium Vaccine Product Offered
11.14.3 Genus Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Genus Main Business Overview
11.14.5 Genus Latest Developments
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Information
11.15.2 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Product Offered
11.15.3 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Hygieia Biological Laboratories Main Business Overview
11.15.5 Hygieia Biological Laboratories Latest Developments
11.16 Nexvet
11.16.1 Nexvet Company Information
11.16.2 Nexvet Veterinary Clostridium Vaccine Product Offered
11.16.3 Nexvet Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Nexvet Main Business Overview
11.16.5 Nexvet Latest Developments
11.17 Nuovo Biologics
11.17.1 Nuovo Biologics Company Information
11.17.2 Nuovo Biologics Veterinary Clostridium Vaccine Product Offered
11.17.3 Nuovo Biologics Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Nuovo Biologics Main Business Overview
11.17.5 Nuovo Biologics Latest Developments
11.18 Valneva
11.18.1 Valneva Company Information
11.18.2 Valneva Veterinary Clostridium Vaccine Product Offered
11.18.3 Valneva Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Valneva Main Business Overview
11.18.5 Valneva Latest Developments
11.19 Vetoquinol
11.19.1 Vetoquinol Company Information
11.19.2 Vetoquinol Veterinary Clostridium Vaccine Product Offered
11.19.3 Vetoquinol Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Vetoquinol Main Business Overview
11.19.5 Vetoquinol Latest Developments
11.20 Virbac
11.20.1 Virbac Company Information
11.20.2 Virbac Veterinary Clostridium Vaccine Product Offered
11.20.3 Virbac Veterinary Clostridium Vaccine Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Virbac Main Business Overview
11.20.5 Virbac Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. H1N1 Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. H1N1 Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Intramuscular Vaccines
Table 4. Major Players of Intranasal Vaccines
Table 5. Major Players of Intradermal Vaccines
Table 6. Global H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global H1N1 Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global H1N1 Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global H1N1 Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global H1N1 Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global H1N1 Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global H1N1 Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global H1N1 Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global H1N1 Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global H1N1 Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global H1N1 Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global H1N1 Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global H1N1 Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global H1N1 Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global H1N1 Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers H1N1 Vaccines Producing Area Distribution and Sales Area
Table 22. Players H1N1 Vaccines Products Offered
Table 23. H1N1 Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global H1N1 Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global H1N1 Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global H1N1 Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global H1N1 Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global H1N1 Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global H1N1 Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global H1N1 Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global H1N1 Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas H1N1 Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas H1N1 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC H1N1 Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC H1N1 Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC H1N1 Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe H1N1 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of H1N1 Vaccines
Table 53. Key Market Challenges & Risks of H1N1 Vaccines
Table 54. Key Industry Trends of H1N1 Vaccines
Table 55. H1N1 Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. H1N1 Vaccines Distributors List
Table 58. H1N1 Vaccines Customer List
Table 59. Global H1N1 Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global H1N1 Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas H1N1 Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC H1N1 Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC H1N1 Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe H1N1 Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa H1N1 Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global H1N1 Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global H1N1 Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global H1N1 Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global H1N1 Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Abbott Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Abbott H1N1 Vaccines Product Portfolios and Specifications
Table 75. Abbott H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. Baxter International Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter International H1N1 Vaccines Product Portfolios and Specifications
Table 80. Baxter International H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Baxter International Main Business
Table 82. Baxter International Latest Developments
Table 83. Sanofi Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi H1N1 Vaccines Product Portfolios and Specifications
Table 85. Sanofi H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. GSK Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK H1N1 Vaccines Product Portfolios and Specifications
Table 90. GSK H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Pfizer Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer H1N1 Vaccines Product Portfolios and Specifications
Table 95. Pfizer H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Mitsubishi Tanabe Pharma Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolios and Specifications
Table 100. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Mitsubishi Tanabe Pharma Main Business
Table 102. Mitsubishi Tanabe Pharma Latest Developments
Table 103. Hualan Biological Engineering Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Engineering H1N1 Vaccines Product Portfolios and Specifications
Table 105. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Hualan Biological Engineering Main Business
Table 107. Hualan Biological Engineering Latest Developments
Table 108. Cipla Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla H1N1 Vaccines Product Portfolios and Specifications
Table 110. Cipla H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Merck Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck H1N1 Vaccines Product Portfolios and Specifications
Table 115. Merck H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Merck Main Business
Table 117. Merck Latest Developments
Table 118. Sinovac Biotech Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinovac Biotech H1N1 Vaccines Product Portfolios and Specifications
Table 120. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Sinovac Biotech Main Business
Table 122. Sinovac Biotech Latest Developments
Table 1. H1N1 Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. H1N1 Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Intramuscular Vaccines
Table 4. Major Players of Intranasal Vaccines
Table 5. Major Players of Intradermal Vaccines
Table 6. Global H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 7. Global H1N1 Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global H1N1 Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global H1N1 Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global H1N1 Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global H1N1 Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global H1N1 Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global H1N1 Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global H1N1 Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global H1N1 Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global H1N1 Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global H1N1 Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global H1N1 Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global H1N1 Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global H1N1 Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers H1N1 Vaccines Producing Area Distribution and Sales Area
Table 22. Players H1N1 Vaccines Products Offered
Table 23. H1N1 Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global H1N1 Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global H1N1 Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global H1N1 Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global H1N1 Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global H1N1 Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global H1N1 Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global H1N1 Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global H1N1 Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas H1N1 Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas H1N1 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 38. Americas H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC H1N1 Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC H1N1 Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC H1N1 Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 43. APAC H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe H1N1 Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 47. Europe H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa H1N1 Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa H1N1 Vaccines Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa H1N1 Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of H1N1 Vaccines
Table 53. Key Market Challenges & Risks of H1N1 Vaccines
Table 54. Key Industry Trends of H1N1 Vaccines
Table 55. H1N1 Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. H1N1 Vaccines Distributors List
Table 58. H1N1 Vaccines Customer List
Table 59. Global H1N1 Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global H1N1 Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas H1N1 Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC H1N1 Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC H1N1 Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe H1N1 Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa H1N1 Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa H1N1 Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global H1N1 Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global H1N1 Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global H1N1 Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global H1N1 Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Abbott Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Abbott H1N1 Vaccines Product Portfolios and Specifications
Table 75. Abbott H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. Baxter International Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter International H1N1 Vaccines Product Portfolios and Specifications
Table 80. Baxter International H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Baxter International Main Business
Table 82. Baxter International Latest Developments
Table 83. Sanofi Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi H1N1 Vaccines Product Portfolios and Specifications
Table 85. Sanofi H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. GSK Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK H1N1 Vaccines Product Portfolios and Specifications
Table 90. GSK H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Pfizer Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer H1N1 Vaccines Product Portfolios and Specifications
Table 95. Pfizer H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Mitsubishi Tanabe Pharma Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolios and Specifications
Table 100. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Mitsubishi Tanabe Pharma Main Business
Table 102. Mitsubishi Tanabe Pharma Latest Developments
Table 103. Hualan Biological Engineering Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Biological Engineering H1N1 Vaccines Product Portfolios and Specifications
Table 105. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Hualan Biological Engineering Main Business
Table 107. Hualan Biological Engineering Latest Developments
Table 108. Cipla Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla H1N1 Vaccines Product Portfolios and Specifications
Table 110. Cipla H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Merck Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck H1N1 Vaccines Product Portfolios and Specifications
Table 115. Merck H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Merck Main Business
Table 117. Merck Latest Developments
Table 118. Sinovac Biotech Basic Information, H1N1 Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Sinovac Biotech H1N1 Vaccines Product Portfolios and Specifications
Table 120. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Sinovac Biotech Main Business
Table 122. Sinovac Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of H1N1 Vaccines
Figure 2. H1N1 Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global H1N1 Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global H1N1 Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. H1N1 Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. H1N1 Vaccines Sales Market Share by Country/Region (2024)
Figure 10. H1N1 Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Intramuscular Vaccines
Figure 12. Product Picture of Intranasal Vaccines
Figure 13. Product Picture of Intradermal Vaccines
Figure 14. Global H1N1 Vaccines Sales Market Share by Type in 2025
Figure 15. Global H1N1 Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. H1N1 Vaccines Consumed in Influenza
Figure 17. Global H1N1 Vaccines Market: Influenza (2020-2025) & (K Units)
Figure 18. H1N1 Vaccines Consumed in Meningococcal
Figure 19. Global H1N1 Vaccines Market: Meningococcal (2020-2025) & (K Units)
Figure 20. H1N1 Vaccines Consumed in Cervical Cancer
Figure 21. Global H1N1 Vaccines Market: Cervical Cancer (2020-2025) & (K Units)
Figure 22. H1N1 Vaccines Consumed in Pneumococcal
Figure 23. Global H1N1 Vaccines Market: Pneumococcal (2020-2025) & (K Units)
Figure 24. H1N1 Vaccines Consumed in Hepatitis
Figure 25. Global H1N1 Vaccines Market: Hepatitis (2020-2025) & (K Units)
Figure 26. H1N1 Vaccines Consumed in Measles
Figure 27. Global H1N1 Vaccines Market: Measles (2020-2025) & (K Units)
Figure 28. H1N1 Vaccines Consumed in Mumps
Figure 29. Global H1N1 Vaccines Market: Mumps (2020-2025) & (K Units)
Figure 30. H1N1 Vaccines Consumed in Rubella
Figure 31. Global H1N1 Vaccines Market: Rubella (2020-2025) & (K Units)
Figure 32. H1N1 Vaccines Consumed in Others
Figure 33. Global H1N1 Vaccines Market: Others (2020-2025) & (K Units)
Figure 34. Global H1N1 Vaccines Sale Market Share by Application (2024)
Figure 35. Global H1N1 Vaccines Revenue Market Share by Application in 2025
Figure 36. H1N1 Vaccines Sales by Company in 2025 (K Units)
Figure 37. Global H1N1 Vaccines Sales Market Share by Company in 2025
Figure 38. H1N1 Vaccines Revenue by Company in 2025 ($ millions)
Figure 39. Global H1N1 Vaccines Revenue Market Share by Company in 2025
Figure 40. Global H1N1 Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 41. Global H1N1 Vaccines Revenue Market Share by Geographic Region in 2025
Figure 42. Americas H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 43. Americas H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 44. APAC H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 45. APAC H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 46. Europe H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 47. Europe H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 48. Middle East & Africa H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 49. Middle East & Africa H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 50. Americas H1N1 Vaccines Sales Market Share by Country in 2025
Figure 51. Americas H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Figure 52. Americas H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 53. Americas H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 54. United States H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Canada H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Mexico H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Brazil H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. APAC H1N1 Vaccines Sales Market Share by Region in 2025
Figure 59. APAC H1N1 Vaccines Revenue Market Share by Region (2020-2025)
Figure 60. APAC H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 61. APAC H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 62. China H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Japan H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. South Korea H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Southeast Asia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. India H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Australia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. China Taiwan H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Europe H1N1 Vaccines Sales Market Share by Country in 2025
Figure 70. Europe H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Figure 71. Europe H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Europe H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Germany H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. France H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. UK H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Italy H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. Russia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Middle East & Africa H1N1 Vaccines Sales Market Share by Country (2020-2025)
Figure 79. Middle East & Africa H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 80. Middle East & Africa H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 81. Egypt H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 82. South Africa H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 83. Israel H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 84. Turkey H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 85. GCC Countries H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of H1N1 Vaccines in 2025
Figure 87. Manufacturing Process Analysis of H1N1 Vaccines
Figure 88. Industry Chain Structure of H1N1 Vaccines
Figure 89. Channels of Distribution
Figure 90. Global H1N1 Vaccines Sales Market Forecast by Region (2026-2031)
Figure 91. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 92. Global H1N1 Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 93. Global H1N1 Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 94. Global H1N1 Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 95. Global H1N1 Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of H1N1 Vaccines
Figure 2. H1N1 Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global H1N1 Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global H1N1 Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. H1N1 Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. H1N1 Vaccines Sales Market Share by Country/Region (2024)
Figure 10. H1N1 Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Intramuscular Vaccines
Figure 12. Product Picture of Intranasal Vaccines
Figure 13. Product Picture of Intradermal Vaccines
Figure 14. Global H1N1 Vaccines Sales Market Share by Type in 2025
Figure 15. Global H1N1 Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. H1N1 Vaccines Consumed in Influenza
Figure 17. Global H1N1 Vaccines Market: Influenza (2020-2025) & (K Units)
Figure 18. H1N1 Vaccines Consumed in Meningococcal
Figure 19. Global H1N1 Vaccines Market: Meningococcal (2020-2025) & (K Units)
Figure 20. H1N1 Vaccines Consumed in Cervical Cancer
Figure 21. Global H1N1 Vaccines Market: Cervical Cancer (2020-2025) & (K Units)
Figure 22. H1N1 Vaccines Consumed in Pneumococcal
Figure 23. Global H1N1 Vaccines Market: Pneumococcal (2020-2025) & (K Units)
Figure 24. H1N1 Vaccines Consumed in Hepatitis
Figure 25. Global H1N1 Vaccines Market: Hepatitis (2020-2025) & (K Units)
Figure 26. H1N1 Vaccines Consumed in Measles
Figure 27. Global H1N1 Vaccines Market: Measles (2020-2025) & (K Units)
Figure 28. H1N1 Vaccines Consumed in Mumps
Figure 29. Global H1N1 Vaccines Market: Mumps (2020-2025) & (K Units)
Figure 30. H1N1 Vaccines Consumed in Rubella
Figure 31. Global H1N1 Vaccines Market: Rubella (2020-2025) & (K Units)
Figure 32. H1N1 Vaccines Consumed in Others
Figure 33. Global H1N1 Vaccines Market: Others (2020-2025) & (K Units)
Figure 34. Global H1N1 Vaccines Sale Market Share by Application (2024)
Figure 35. Global H1N1 Vaccines Revenue Market Share by Application in 2025
Figure 36. H1N1 Vaccines Sales by Company in 2025 (K Units)
Figure 37. Global H1N1 Vaccines Sales Market Share by Company in 2025
Figure 38. H1N1 Vaccines Revenue by Company in 2025 ($ millions)
Figure 39. Global H1N1 Vaccines Revenue Market Share by Company in 2025
Figure 40. Global H1N1 Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 41. Global H1N1 Vaccines Revenue Market Share by Geographic Region in 2025
Figure 42. Americas H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 43. Americas H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 44. APAC H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 45. APAC H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 46. Europe H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 47. Europe H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 48. Middle East & Africa H1N1 Vaccines Sales 2020-2025 (K Units)
Figure 49. Middle East & Africa H1N1 Vaccines Revenue 2020-2025 ($ millions)
Figure 50. Americas H1N1 Vaccines Sales Market Share by Country in 2025
Figure 51. Americas H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Figure 52. Americas H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 53. Americas H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 54. United States H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Canada H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Mexico H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Brazil H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. APAC H1N1 Vaccines Sales Market Share by Region in 2025
Figure 59. APAC H1N1 Vaccines Revenue Market Share by Region (2020-2025)
Figure 60. APAC H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 61. APAC H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 62. China H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Japan H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. South Korea H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Southeast Asia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. India H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Australia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. China Taiwan H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Europe H1N1 Vaccines Sales Market Share by Country in 2025
Figure 70. Europe H1N1 Vaccines Revenue Market Share by Country (2020-2025)
Figure 71. Europe H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 72. Europe H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 73. Germany H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. France H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. UK H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Italy H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. Russia H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Middle East & Africa H1N1 Vaccines Sales Market Share by Country (2020-2025)
Figure 79. Middle East & Africa H1N1 Vaccines Sales Market Share by Type (2020-2025)
Figure 80. Middle East & Africa H1N1 Vaccines Sales Market Share by Application (2020-2025)
Figure 81. Egypt H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 82. South Africa H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 83. Israel H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 84. Turkey H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 85. GCC Countries H1N1 Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of H1N1 Vaccines in 2025
Figure 87. Manufacturing Process Analysis of H1N1 Vaccines
Figure 88. Industry Chain Structure of H1N1 Vaccines
Figure 89. Channels of Distribution
Figure 90. Global H1N1 Vaccines Sales Market Forecast by Region (2026-2031)
Figure 91. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 92. Global H1N1 Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 93. Global H1N1 Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 94. Global H1N1 Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 95. Global H1N1 Vaccines Revenue Market Share Forecast by Application (2026-2031)
